About us Pricing ContactSubscribe

A

Alexander M.M. Eggermont

Université Paris-SaclayORCID https://orcid.org/0000-0002-4278-040X

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

New England Journal of Medicine20117,653 citations

Final Version of 2009 AJCC Melanoma Staging and Classification

Journal of Clinical Oncology20094,551 citations

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

CA A Cancer Journal for Clinicians20172,248 citations

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

The Lancet Oncology20151,554 citations

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Annals of Oncology20171,280 citations

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Clinical Cancer Research20161,185 citations

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

Annals of Oncology2015885 citations

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

European Journal of Cancer2016574 citations

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

European Journal of Cancer2017555 citations